The Gut Microbiome at the Center of a Signaling Network Affecting Health and Aging
The state of the gut microbiome is at least as influential on long term health as lifestyle choices like exercise. The composition of the gut microbiome changes with age for reasons yet to be fully explored. Inflammatory populations grow at the expense of populations producing metabolites necessary for tissue function. Connections can be drawn between near every organ and system in the body and specific metabolites or specific microbial populations influencing them. In turn the immune system and other organs influence the gut microbiome. Fortunately, it is possible to produce the lasting restoration of a more youthful gut microbiome via strategies such as flagellin immunization and fecal microbiota transplantation. Unfortunately, probiotic and related strategies are as yet incapable of producing such sizable and lasting changes, though there is hope that much more complex and carefully designed probiotic mixes could in the future approach the results obtained via fecal microbiota transplantation.
The intestine engages in communication with various distant organs through neural, immune, and endocrine pathways. This systemic interconnection mechanism is referred to as the gut-organ axis, in which gut microbiota play a central role. This review systematically examines the complex and bidirectional interactions between the gut microbiota and the brain, liver, lungs, kidneys, bones, heart, skin, germline, and immune system. Central to these interactions are microbial metabolites - fatty acids, secondary bile acids, and tryptophan derivatives - that act as crucial systemic signals engaging key receptors in the brain, liver, and beyond.
Studies demonstrated that the composition of the gut microbiota and alterations in its metabolites can directly or indirectly regulate the physiological and pathological processes of various organs. Biological therapies, such as fecal microbiota transplantation and probiotic interventions, can establish a healthy intestinal environment by reshaping the intestinal microecology, thereby positively influencing related diseases. The therapeutic landscape is rapidly evolving, with next-generation probiotics, postbiotics, and engineered strains now enabling precise, targeted remodeling of the gut ecosystem to restore host homeostasis and treat multi-organ diseases. This review articulates how the gut microbiota integrates environmental cues into a multi-organ regulatory network, underscoring its potential as a therapeutic target for systemic diseases.